Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

U.S. Sens. Mark R. Warner and Tim Kaine, a member of the Senate Health, Education, Labor and Pensions Committee, (both D-VA) ...

The proposed cuts would place a 15% indirect cost rate on all new and existing grant awards received by research institutions and universities.

After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...

Calling the cuts "arbitrary and capricious," 22 states sued the Trump administration Feb. 10 – the day they were set to take effect – with lawsuits following from the Associat ...

Washington University Chancellor Andrew Martin said the funding changes could be "potentially catastrophic" for the ...

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

In statements and interviews with The Crimson, nine life sciences researchers at Harvard — from the Harvard School of Public ...

Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...

New research grant funding rules reportedly instituted by Elon Musk's DOGE would have profound impacts on San Diego, where a ...